CCK-B ANTAGONISTS EXHIBIT ANTIDEPRESSANT-LIKE EFFECTS AND POTENTIATE ENDOGENOUS ENKEPHALIN ANALGESIA - CORRELATION WITH IN-VIVO BINDING AFFINITIES AND BRAIN PENETRATION

被引：7

作者：

DURIEUX, C

DERRIEN, M

MALDONADO, R

VALVERDE, O

BLOMMAERT, A

FOURNIEZALUSKI, MC

ROQUES, BP

机构：

[1] Laboratoire de Pharmacochimie Moléculaire et Structurale, INSERM U 266, CNRS, URA D 1500, Paris, 75006, 4, avenue de l'Observatoire

来源：

CHOLECYSTOKININ | 1994年 / 713卷

关键词：

D O I：

10.1111/j.1749-6632.1994.tb44091.x

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：355 / 357

页数：3

共 6 条

[1] ANTIDEPRESSANT-TYPE EFFECTS OF ENDOGENOUS ENKEPHALINS PROTECTED BY SYSTEMIC RB-101 ARE MEDIATED BY OPIOID-DELTA AND DOPAMINE-D1 RECEPTOR STIMULATION [J].

BAAMONDE, A ;

DAUGE, V ;

RUIZGAYO, M ;

FULGA, IG ;

TURCAUD, S ;

FOURNIEZALUSKI, MC ;

ROQUES, BP .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 216 (02) :157-166

[2]

BLOMMAERT AGS, 1993, IN PRESS J MED CHEM

[3] INVIVO BINDING AFFINITIES OF CHOLECYSTOKININ AGONISTS AND ANTAGONISTS DETERMINED USING THE SELECTIVE CCKB AGONIST (H-3)PBC 264 [J].

DURIEUX, C ;

RUIZGAYO, M ;

ROQUES, BP .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 209 (03) :185-193

[4]

EDDY NB, 1953, J PHARMACOL EXP THER, V107, P385

[5]

KAMEYAMA T, 1982, PHARMACOL BIOCHEM BE, V17, P59

[6]

NOBLE F, 1992, J PHARMACOL EXP THER, V261, P181

← 1 →